It acts as a penultimate, chiral precursor that is hydrolyzed (typically with NaOH) to yield the final carboxylic acid drug. 2-Ethoxy-4-(3-((S)-3-methy-1-(2-piperidin-1-yl-phenyl)-butylamino)-2-oxo-propyl)-benzoic acid ethyl ester, often known as Repaglinide ethyl ester, is a critical intermediate in the final synthesis of the antidiabetic drug Repaglinide.
2-Ethoxy-4-(3-((S)-3-methy-1-(2-piperidin-1-yl-phenyl)-butylamino)-2-oxo-propyl)-benzoic acid ethyl ester
| API Name | Repaglinide |
|---|---|
| CAS No | 147770-06-7 |
| Molecular Formula | C29H40N2O4 |
| Molecular Weight | 480.6 g/mol |
| Synonyms | ethyl 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoate |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
It acts as a penultimate, chiral precursor that is hydrolyzed (typically with NaOH) to yield the final carboxylic acid drug. 2-Ethoxy-4-(3-((S)-3-methy-1-(2-piperidin-1-yl-phenyl)-butylamino)-2-oxo-propyl)-benzoic acid ethyl ester, often known as Repaglinide ethyl ester, is a critical intermediate in the final synthesis of the antidiabetic drug Repaglinide.
The CAS number of 2-Ethoxy-4-(3-((S)-3-methy-1-(2-piperidin-1-yl-phenyl)-butylamino)-2-oxo-propyl)-benzoic acid ethyl ester is 147770-06-7.
The molecular formula of 2-Ethoxy-4-(3-((S)-3-methy-1-(2-piperidin-1-yl-phenyl)-butylamino)-2-oxo-propyl)-benzoic acid ethyl ester is C29H40N2O4.
The listed molecular weight of 2-Ethoxy-4-(3-((S)-3-methy-1-(2-piperidin-1-yl-phenyl)-butylamino)-2-oxo-propyl)-benzoic acid ethyl ester is 480.6 g/mol.
2-Ethoxy-4-(3-((S)-3-methy-1-(2-piperidin-1-yl-phenyl)-butylamino)-2-oxo-propyl)-benzoic acid ethyl ester is listed as being used in connection with the following API: Repaglinide.
The listed synonym or IUPAC name for 2-Ethoxy-4-(3-((S)-3-methy-1-(2-piperidin-1-yl-phenyl)-butylamino)-2-oxo-propyl)-benzoic acid ethyl ester is ethyl 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoate.